{
  "id": 2868507,
  "title": "Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?",
  "url": "https://urgent.news/2026/08/23/better-dividend-king-to-buy-right-now-abbott-labs-or-johnson-johnson-2868507",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-23T20:20:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/better-dividend-king-buy-right-now-abbott-labs-or-johnson-johnson"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsAbbott Laboratories has faced challenges, but it should successfully overcome them.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?",
        "url": "https://urgent.news/2026/08/23/better-dividend-king-to-buy-right-now-abbott-labs-or-johnson-johnson",
        "published": "2026-08-23T20:00:00.000Z"
      },
      {
        "outlet": "Yahoo Finance",
        "title": "Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?",
        "url": "https://urgent.news/2026/08/23/better-dividend-king-to-buy-right-now-abbott-labs-or-johnson-johnson-2862600",
        "published": "2026-08-23T20:20:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}